Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature

Statin therapy with or without ezetimibe and the progression to diabetes

(2016) Fotios Barkas et al.   Journal of Clinical Lipidology

Clinical and genetic analysis of a family diagnosed with familial hypobetalipoproteinemia in which the proband was diagnosed with diabetes mellitus

(2015) Xiaoli Wang et al.   ATHEROSCLEROSIS

Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes

(2015) Antonio J. Vallejo-Vaz et al.   ATHEROSCLEROSIS

Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin

(2015) Lorenzo Arnaboldi et al.   ATHEROSCLEROSIS SUPPLEMENTS

Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus

(2015) Joost Besseling et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion

(2015) Yan Wang et al.   JOURNAL OF LIPID RESEARCH

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

(2015) Daniel I Swerdlow et al.   LANCET

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

(2015) L. Shamseer et al.   BMJ-British Medical Journal

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

(2015) L. Shamseer et al.   BMJ-British Medical Journal

Differential Association of Plasma Angiopoietin-Like Proteins 3 and 4 With Lipid and Metabolic Traits

(2014) Nidhi Mehta et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Hypobetalipoproteinemia and abetalipoproteinemia

(2014) Francine K. Welty   CURRENT OPINION IN LIPIDOLOGY

Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia

(2014) Mathilde Di Filippo et al.   JOURNAL OF HEPATOLOGY

Statin treatment and new-onset diabetes: A review of proposed mechanisms

(2014) Marilyne Brault et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Angptl3 Deficiency Is Associated With Increased Insulin Sensitivity, Lipoprotein Lipase Activity, and Decreased Serum Free Fatty Acids

(2013) Marius R. Robciuc et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia

(2013) Angelo B. Cefalù et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia

(2013) Liesl V. Heeks et al.   CLINICA CHIMICA ACTA

Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis

(2013) Ilenia Minicocci et al.   JOURNAL OF LIPID RESEARCH

Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia

(2012) Davide Noto et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology

(2012) Claudia Della Corte et al.   CLINICAL ENDOCRINOLOGY

The impact of severe LDL receptor mutations on SREBP-pathway regulation in homozygous familial hypercholesterolemia (FH)

(2012) Muhidien Soufi et al.   GENE

Atypical angiopoietin-like protein that regulates ANGPTL3

(2012) F. Quagliarini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study

(2011) Davide Noto et al.   ACTA DIABETOLOGICA

Plasma non-cholesterol sterols in primary hypobetalipoproteinemia

(2011) Davide Noto et al.   ATHEROSCLEROSIS

Regulation of triglyceride metabolism by Angiopoietin-like proteins

(2011) Frits Mattijssen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia

(2011) M. E. Visser et al.   DIABETOLOGIA

Pitavastatin Increases ABCA1 Expression by Dual Mechanisms: SREBP2-Driven Transcriptional Activation and PPARα-Dependent Protein Stabilization but Without Activating LXR in Rat Hepatoma McARH7777 Cells

(2011) Takashi Maejima et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption

(2011) T.A. Miettinen et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Liver X Receptor Signaling Pathways and Atherosclerosis

(2010) Anna C. Calkin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial Hypobetalipoproteinemia

(2010) Anastassia Amaro et al.   GASTROENTEROLOGY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Exome Sequencing,ANGPTL3Mutations, and Familial Combined Hypolipidemia

(2010) Kiran Musunuru et al.   NEW ENGLAND JOURNAL OF MEDICINE

Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia

(2009) Davide Noto et al.   ATHEROSCLEROSIS

Liver X receptor in cholesterol metabolism

(2009) Chunyan Zhao et al.   JOURNAL OF ENDOCRINOLOGY

HNF1α and SREBP2 are important regulators of NPC1L1 in human liver

(2009) Camilla Pramfalk et al.   JOURNAL OF LIPID RESEARCH

LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor

(2009) Noam Zelcer et al.   SCIENCE

Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia

(2008) Shoji Katsuda et al.   CLINICA CHIMICA ACTA

Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B

(2008) Dominique Bonnefont-Rousselot et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis

(2008)   LANCET

The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: Results of a 15 years follow-up in a Mediterranean population

(2007) Davide Noto et al.   ATHEROSCLEROSIS